Chair of the Firm’s Business Litigation and Dispute Resolution Practice Group, Scott tries and defends cases in state and federal court, as well as in arbitration. In his nearly twenty years of practice, Scott has represented pharmaceutical manufacturers, distributors, wholesalers, and life sciences start-ups; banking, real estate, and private equity firms; and aircraft / industrial equipment manufacturers in a variety of tort, contract, and commercial disputes.
Scott's practice focuses on: government investigations and litigation under federal and state False Claims Act (whistleblower / qui tam) statutes; products liability and MDL defense; and defending and prosecuting commercial and tort claims on behalf of the Firm's private equity, lending, and real estate clients. In addition to first-chairing jury and non-jury trials, as well as arbitrations before FINRA and AAA, Scott also has represented current and former company employees, officers, and directors compelled to provide sworn testimony in connection with litigation and government-led investigations.
Scott also handles government audits and investigations, including those initiated by state and federal enforcement officials, on behalf of his clients as well as their officers and employees. Frequently, these matters focus on issues involving defense and other government contracts, pharmaceutical pricing, and the marketing and sale of medications and defense equipment paid for or reimbursed by the government. Such representation often involves issues arising under the False Claims Act, federal and state Anti-Kickback laws, the Medicaid Rebate Act, and the Stark Law.